• IMA sites
  • IMAJ services
  • IMA journals
  • Follow us
  • Alternate Text Alternate Text
עמוד בית
Sat, 22.06.24

LETTERS

IMAJ | volume 23

Journal 11, November 2021
pages: 751

Comment on: Efficacy and safety of enteral recombinant human insulin for reduction of time-to-full enteral feeding in preterm infants: a randomized, double-blind, placebo-controlled trial (IMAJ September 2021)

Summary

Keywords:

Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter.
The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.
© All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy

2 Twin Towers, 35 Jabotinsky, POB 4292, Ramat Gan 5251108 Israel